SHIM
GILD icon

Stone House Investment Management’s Gilead Sciences GILD Stock Holding History

Stone House Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.2K Buy
124
+111
+854% +$15.5K ﹤0.01% 288
2025
Q4 		$1.6K Buy
13
+3
+30% +$365 ﹤0.01% 579
2025
Q3 		$1.11K Buy
10
+2
+25% +$227 ﹤0.01% 550
2025
Q2 		$887 Buy
+8
New +$851 ﹤0.01% 463
2024
Q2 		– Sell
-34
Closed -$2.49K – 407
2024
Q1 		$2.49K Buy
+34
New +$2.61K ﹤0.01% 329

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Stone House Investment Management's GILD Position: Q1 2026 in Review

Stone House Investment Management increased its Gilead Sciences (GILD) stake by 854% in Q1 2026, buying an estimated $15.5K and bringing the position to 124 shares worth $17.2K. The position accounts for ﹤0.01% of the portfolio, ranked #288.

Stone House Investment Management first reported a position in GILD in Q1 2024 and has held it in 5 quarters since. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Stone House Investment Management held 124 shares of Gilead Sciences worth $17.2K as of Q1 2026.
  • Stone House Investment Management bought 111 Gilead Sciences shares in Q1 2026, an estimated $15.5K.
  • Gilead Sciences made up ﹤0.01% of Stone House Investment Management's portfolio in Q1 2026, its #288 holding.
  • Stone House Investment Management first reported a position in Gilead Sciences in Q1 2024 and has held it in 5 quarters since.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Stone House Investment Management's 13F filing for Q1 2026, filed 22 Apr 2026.